SMTL ID : 8uoi.1

Crystal structure of human NUAK1-MARK3 kinase domain chimera bound with small molecule inhibitor #65

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x X3Q: (7M)-7-[(4S)-imidazo[1,2-b]pyridazin-3-yl]-1-[(1R)-1-phenylethyl]-3-(piperazin-1-yl)pyrido[3,4-b]pyrazin-2(1H)-one(Non-covalent)

X3Q.1: 18 residues within 4Å: Chain A: L.20, G.21, V.28, A.41, I.74, M.90, E.91, Y.92, A.93, G.96, E.97, D.100, E.140, N.141, L.143, A.153 Ligands: EDO.3, EDO.6 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:L.20, A:V.28, A:A.41, A:I.74, A:L.143, A:A.153 Hydrogen bonds: A:A.93, A:E.97 Water bridges: A:G.96, A:D.100, A:D.100

5 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 3 residues within 4Å: Chain A: K.227, Y.228, I.230 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:Y.228 EDO.3: 6 residues within 4Å: Chain A: V.28, K.43, E.61, M.90, D.154 Ligands: X3Q.1 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:E.61 Water bridges: A:F.155, A:G.156 EDO.4: 2 residues within 4Å: Chain A: I.230, E.239 1 PLIP interactions: 1 interactions with chain A Water bridges: A:E.239 EDO.5: 5 residues within 4Å: Chain A: E.180, Q.183, K.185, L.248, P.250 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:K.185 EDO.6: 4 residues within 4Å: Chain A: K.22, G.23, A.26 Ligands: X3Q.1 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Poullennec, K.G. et al., Discovery of UCB9386: A Potent, Selective, and Brain-Penetrant Nuak1 Inhibitor Suitable for In Vivo Pharmacological Studies. J.Med.Chem. (2024)

Release Date

2024-10-23

Peptides

MAP/microtubule affinity-regulating kinase 3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

MAP/microtubule affinity-regulating kinase 3

Related Entries With Identical Sequence